An unmet need for implantable cardioverter-defibrillators in New Zealand

Europace

Volumn 13, Issue 9, 2011, Pages 1299-1303

  Burgess, Sonya N ^a   Harding, Scott A ^a   Melton, Iain C ^b   Lever, Nigel A ^c,d   Swain, Andrew H ^e   Shi, Bijia ^e   Larsen, Peter D ^e  

^a WELLINGTON HOSPITAL   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Implantable Cardioverter defibrillator; Sudden cardiac death

Indexed keywords

ADULT; ARTICLE; CARDIOVERSION; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; HEART ARREST; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; PRIORITY JOURNAL; SUDDEN DEATH; TREATMENT INDICATION;

AGED; COMORBIDITY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; RETROSPECTIVE STUDIES; STROKE VOLUME; SYNCOPE; TREATMENT OUTCOME;

EID: 80052214521     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur113     Document Type: Article

References (18)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-83.
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37. (Pubitemid 40110811)
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83. (Pubitemid 34984635)
4. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;51:e1-e62.
5. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H et al. Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Europace 2007;9:959-98.
6. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/ AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines For Management Of Patients With Ventricular Arrhythmias And The Prevention Of Sudden Cardiac Death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:746-837.
7. Larsen PD, De Silva P, Harding SA, Woodcock E, Lever NA. Use of implantable cardioverter defibrillators in the New Zealand context from 2000 to 2007. N Z Med J 2010;123:76-85.
8. Mond HG, Whitlock RM. The Australian and New Zealand cardiac pacing and implantable cardioverter-defibrillator survey: Calendar year 2005. Heart Lung Circ 2008;17:85-9. (Pubitemid 351377552)
9. Camm AJ, Nisam S. European utilization of the implantable defibrillator: Has 10 years changed the 'enigma'? Europace 2010;12:1063-9.
10. van Veldhuisen DJ, Maass AH, Priori SG, Stolt P, van Gelder IC, Dickstein K et al. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: Changes from 2004 to 2008. Eur J Heart Fail 2009;11:1143-51.
11. OECD Health Data 2008 http://www.oecd.org/document/30/0,3343, en-2649-34631-12968734-1-1-1-1,00.html (November 2010, date last accessed).
12. Stecker EC, Vickers C,Waltz J, Socoteanu C, John BT, Mariani R et al. Populationbased analysis of sudden cardiac death with and without left ventricular systolic dysfunction: Two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol 2006;47:1161-6.
13. Chase D, Roderick PJ, Burnley H, Gallagher PJ, Roberts PR, Morgan JM. Is there unmet need for implantable cardioverter defibrillators? Findings from a postmortem series of sudden cardiac death. Europace 2008;10:741-6. (Pubitemid 351775280)
14. McHale B, Harding SA, Lever NA, Larsen PD. A national survey of clinician's knowledge of and attitudes towards implantable cardioverter defibrillators. Europace 2009;11:1313-6.
15. Plummer CJ, John Irving R, McComb JM. The incidence of implantable cardioverter defibrillator indications in patients admitted to all coronary care units in a single district. Europace 2005;7:266-72. (Pubitemid 40614365)
16. Scott PA, Gorman S, Andrews NP, Roberts PR, Kalra PR. Estimation of the requirement for implantable cardioverter defibrillators for the primary prevention of sudden cardiac death post-myocardial infarction based on UK national guidelines (2006). Europace 2008;10:453-7. (Pubitemid 351767674)
17. Myerburg RJ, Castellanos A. Emerging paradigms of the epidemiology and demographics of sudden cardiac arrest. Heart Rhythm 2006;3:235-9. (Pubitemid 43150000)
18. Myerburg R. Scientific gaps in the prediction and prevention of sudden cardiac death. J Cardiovasc Electrophysiol 2002;13:709-23. (Pubitemid 34774912)